Dr. Turner on Important Steps for Genomic Profiling in Gynecologic Malignancies

Video

In Partnership With:

Taylor Turner, MD, fellow, University of Alabama at Birmingham School of Medicine, discusses important steps to implement a genomic profiling program for gynecologic malignancies.

Taylor Turner, MD, fellow, University of Alabama at Birmingham School of Medicine, discusses important steps to implement a genomic profiling program for gynecologic malignancies.

To implement a precision medicine or next-generation sequencing program, Turner says, necessary infrastructure needs to be in place. A pharmacist is needed because physicians will likely be using drugs they’ve never seen before. A dedicated individual is also needed to help interpret the results. A commercial partner will do the best they can, but they don’t normally have the expertise of a clinician in terms of various treatment options. Next, a database is needed to keep track of the rapidly evolving treatment landscape and relevant clinical trials. For example, 2 years ago, a patient with microsatellite instability-high disease didn’t have many treatment options. Now, they can receive immunotherapy.

Turner adds that this shows a lot of promise in non-ovarian malignancies.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD